Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)
NCT01752166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2014-05-26
Summary
The purpose of this study is to validate clinical performance (i.e. estimated sensitivity and specificity) of the T2 Candida test on the T2 DX Instrument compared to blood culture results and/or known Candida positive status of prospectively collected and contrived (i.e. Candida-spiked) clinical specimens.
Conditions
- Candidemia
Sponsors & Collaborators
-
T2 Biosystems
lead INDUSTRY
Principal Investigators
-
Peter Pappas, MD · University of Alabama at Birmingham
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
NCT02333448 ·Status: COMPLETED
-
Antigenic and Antibody Detection of Candida
NCT03766932 ·Status: UNKNOWN
-
Retrospective Chart Review of Candida Fungemia
NCT03827330 ·Status: COMPLETED
-
Bio-assay Development and Implementation for Fungal Infection Detection
NCT02333266 ·Status: WITHDRAWN
-
Early- and Late-onset Candidemia
NCT01406093 ·Status: COMPLETED
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
Invasive Candidiasis in Critical Care
NCT06456151 ·Status: RECRUITING
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
NCT02220790 ·Status: COMPLETED
-
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
NCT05720728 ·Status: COMPLETED
-
Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients
NCT03652194 ·Status: UNKNOWN
-
Nasal Antisepsis for C. Auris Prevention
NCT06282510 ·Status: RECRUITING ·Phase: PHASE4
-
Value of PCT When Diagnosing Candidemia
NCT05385107 ·Status: COMPLETED
-
Efflux Pump Mediated Azole Resistance in Candida Albicans
NCT03659162 ·Status: UNKNOWN
-
Comparison of Uncomplicated Candidemia Therapy Duration in Children
NCT05763251 ·Status: RECRUITING ·Phase: NA
-
Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
NCT00904995 ·Status: COMPLETED ·Phase: PHASE3
-
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
NCT04874441 ·Status: RECRUITING ·Phase: NA
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED
-
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.
NCT03674359 ·Status: UNKNOWN
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia
NCT06907992 ·Status: NOT_YET_RECRUITING
-
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
NCT02629419 ·Status: COMPLETED ·Phase: PHASE2
-
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
NCT00462657 ·Status: UNKNOWN ·Phase: NA